NASDAQ:CHNA Loncar China Biopharma ETF (CHNA) Price, Holdings, & News → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CHNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$13.53▼$13.5350-Day Range$13.53▼$14.7752-Week Range$13.35▼$22.89Volume100 shsAverage Volume538 shsMarket Capitalization$19.35 millionAssets Under Management$3.74 millionDividend Yield0.44%Net Expense Ratio0.79% Stock AnalysisStock Analysis Get Loncar China Biopharma ETF alerts: Email Address About Loncar China Biopharma ETF (NASDAQ:CHNA)The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.Read More Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. CHNA ETF News HeadlinesFebruary 6, 2024 | investing.comMiraeAsset TIGER China Biotech Solactive ETF (371470)January 20, 2024 | investing.comChina Southern CSI Cmunctn Srvcs ETF (159511)April 26, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.December 30, 2023 | nasdaq.comThis ETF Has Depth Needed for China ReboundDecember 21, 2023 | money.usnews.comChina Bans Export of Rare Earths Processing TechnologiesDecember 19, 2023 | msn.comChina Sinochem Buys Rare Venezuelan Oil Cargo After U.S. Suspends Sanctions - SourcesDecember 16, 2023 | investing.comChina Universal Nasdaq 100 ETF (QDII) (159660)December 13, 2023 | investing.comAmundi MSCI China A II ETF (C024)April 26, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… December 12, 2023 | investing.com2823 ETF Stock Price HistorySee More Headlines Receive CHNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerExchange Traded Concepts Fund NameLoncar China Biopharma ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:CHNA Inception Date8/14/2018 Fund ManagerDenise M. Krisko, Habib Moudachirou WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkLoncar China BioPharma Index CategorySector FocusHealth Care Development LevelEmerging Markets RegionAsia-Pacific Number of Holdings89 Fund Statistics Assets Under Management$3.74 million Average Daily Volume$1,200.80 Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorExchange Traded Concepts, LLC CustodianU.S. Bank, N.A. DistributorQuasar Distributors, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerGTS Miscellaneous Outstanding Shares1,430,000Beta0.67 Creation Unit50,000 Creation Fee$750.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Loncar China Biopharma ETF ExpensesTypeCHNAHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.79%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.79%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%Net Expense0.79%0.60%0.60%0.54%0.58% Loncar China Biopharma ETF (CHNA) HoldingsTop 10 CHNA HoldingsGeron(NASDAQ:GERN)Holding Weight: 2.78%Acrivon Therapeutics(NASDAQ:ACRV)Holding Weight: 2.54%Enliven Therapeutics(NASDAQ:ELVN)Holding Weight: 2.20%Janux Therapeutics(NASDAQ:JANX)Holding Weight: 1.82%Nuvation Bio(NYSE:NUVB)Holding Weight: 1.75%2seventy bio(NASDAQ:TSVT)Holding Weight: 1.67%Revolution Medicines(NASDAQ:RVMD)Holding Weight: 1.54%Prelude Therapeutics(NASDAQ:PRLD)Holding Weight: 1.50%Lyell Immunopharma(NASDAQ:LYEL)Holding Weight: 1.48%Adicet Bio(NASDAQ:ACET)Holding Weight: 1.45%Full Holdings Details Similar ETFsProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISJPMorgan Healthcare Leaders ETFNASDAQ:JDOCHorizon Kinetics Medical ETFNASDAQ:MEDXFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQ CHNA ETF - Frequently Asked Questions How often does Loncar China Biopharma ETF pay dividends? What is the dividend yield for Loncar China Biopharma ETF? Loncar China Biopharma ETF announced an annual dividend on Friday, October 13th. Investors of record on Tuesday, October 17th will be given a dividend of $0.0674 per share on Wednesday, October 18th. The ex-dividend date of this dividend is Monday, October 16th. Read our dividend analysis for CHNA. What does CHNA invest in? Loncar China Biopharma ETF is a equity fund issued by Exchange Traded Concepts. CHNA focuses on health care investments and follows the Loncar China BioPharma Index. The fund's investments total to approximately $3.74 million assets under management. What stocks does Loncar China Biopharma ETF hold? CHNA invests in 89 holdings. Some of the stocks in their portfolio include Geron (GERN), Acrivon Therapeutics (ACRV), Enliven Therapeutics (ELVN), Janux Therapeutics (JANX), Nuvation Bio (NUVB), 2seventy bio (TSVT), Revolution Medicines (RVMD), Prelude Therapeutics (PRLD), Lyell Immunopharma (LYEL) and Adicet Bio (ACET). What is the management fee for Loncar China Biopharma ETF? Loncar China Biopharma ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for CHNA is 0.79%. What other stocks do shareholders of Loncar China Biopharma ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China Biopharma ETF investors own include Baidu (BIDU), Salesforce (CRM), Capcom (CCOEY), Alibaba Group (BABA), Activision Blizzard (ATVI), ArcBest (ARCB), Advanced Micro Devices (AMD) and Analog Devices (ADI). This page (NASDAQ:CHNA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Loncar China Biopharma ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.